Search

Your search keyword '"Momas, I."' showing total 571 results

Search Constraints

Start Over You searched for: Author "Momas, I." Remove constraint Author: "Momas, I."
571 results on '"Momas, I."'

Search Results

251. Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes.

252. Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA.

253. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.

254. Early polysensitization is associated with allergic multimorbidity in PARIS birth cohort infants.

255. Allergic sensitisation in early childhood: Patterns and related factors in PARIS birth cohort.

256. In vitro model adapted to the study of skin ageing induced by air pollution.

257. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

258. Human Reconstituted Nasal Epithelium, a promising in vitro model to assess impacts of environmental complex mixtures.

259. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation.

260. Operational Definition of Active and Healthy Ageing (AHA): A Conceptual Framework.

261. Are allergic multimorbidities and IgE polysensitization associated with the persistence or re-occurrence of foetal type 2 signalling? The MeDALL hypothesis.

262. Developmental determinants in non-communicable chronic diseases and ageing.

263. Systematic Review on the Definition of Allergic Diseases in Children: The MeDALL Study.

264. Forced expiratory flows' contribution to lung function interpretation in schoolchildren.

265. New insights into handling missing values in environmental epidemiological studies.

266. A model of human nasal epithelial cells adapted for direct and repeated exposure to airborne pollutants.

267. Integrated care pathways for airway diseases (AIRWAYS-ICPs).

268. Birth cohorts in asthma and allergic diseases: report of a NIAID/NHLBI/MeDALL joint workshop.

269. Childhood allergic asthma is not a single phenotype.

270. Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort study.

271. The development of the MeDALL Core Questionnaires for a harmonized follow-up assessment of eleven European birth cohorts on asthma and allergies.

272. Pregnancy and birth cohort resources in europe: a large opportunity for aetiological child health research.

273. Environmental triggers of nocturnal dry cough in infancy: new insights about chronic domestic exposure to formaldehyde in the PARIS birth cohort.

274. Comparing methods for handling missing data.

275. Dry night cough as a marker of allergy in preschool children: the PARIS birth cohort.

276. Indoor tetrachloroethylene levels and determinants in Paris dwellings.

277. Risk factors and characteristics of respiratory and allergic phenotypes in early childhood.

278. Inflammatory response modulation of airway epithelial cells exposed to formaldehyde.

279. Cough and dyspnoea may discriminate allergic and infectious respiratory phenotypes in infancy.

280. Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminar.

281. [Management of wheezing disorders in infants participating in the PARIS birth cohort].

282. Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper.

283. Sequential air-liquid exposure of human respiratory cells to chemical and biological pollutants.

284. Assessment of indoor environment in Paris child day care centers.

285. Formaldehyde exposure and lower respiratory infections in infants: findings from the PARIS cohort study.

286. Contribution of ozone to airborne aldehyde formation in Paris homes.

287. MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine.

288. Does allergic rhinitis exist in infancy? Findings from the PARIS birth cohort.

289. An in vitro model to evaluate the inflammatory response after gaseous formaldehyde exposure of lung epithelial cells.

291. Urinary arsenic concentrations and speciation in residents living in an area with naturally contaminated soils.

292. Bronchial obstructive phenotypes in the first year of life among Paris birth cohort infants.

293. [Public health and the pharmacist: a challenge of importance regarding training].

294. Assessment and predictors determination of indoor airborne fungal concentrations in Paris newborn babies' homes.

295. [Epidemiology of allergic respiratory disorders in infants].

296. Spatial heterogeneity of personal exposure to airborne metals in French urban areas.

297. The Paris prospective birth cohort study: which design and who participates?

298. Environmental and biological monitoring of exposure to organophosphorus pesticides: application to occupationally and non-occupationally exposed adult populations.

299. Retrospective assessment of exposure to traffic air pollution using the ExTra index in the VESTA French epidemiological study.

300. Can we use fixed ambient air monitors to estimate population long-term exposure to air pollutants? The case of spatial variability in the Genotox ER study.

Catalog

Books, media, physical & digital resources